Showing results (171-180 of 3,272) with videos related to
Sort By:
Pageof 328
Seminars in Arthritis and Rheumatism|November 15, 2016
Unraveling the podocyte injury in lupus nephritis: Clinical and experimental approachesMariane Dos Santos, Priscila Tamar Poletti, Patrícia Milhoransa, et al.Seminars in Arthritis and Rheumatism|November 19, 2016
Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritisJoachim Sieper, Xiaohan Hu, Christopher M Black, et al.Seminars in Arthritis and Rheumatism|December 20, 2016
Gray matter abnormalities associated with fibromyalgia: A meta-analysis of voxel-based morphometric studiesHaiCun Shi, CongHu Yuan, ZhenYu Dai, et al.Seminars in Arthritis and Rheumatism|December 3, 2016
Critical review of the role of intravenous immunoglobulins in idiopathic inflammatory myopathiesSabrina Anh-Tu Hoa, Marie HudsonSeminars in Arthritis and Rheumatism|December 3, 2016
Mortality profile of patients with rheumatoid arthritis in France and its change in 10 yearsJérôme Avouac, Fazia Amrouche, Christophe Meune, et al.Seminars in Arthritis and Rheumatism|December 6, 2016
The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United StatesEric Jutkowitz, Maureen Dubreuil, Na Lu, et al.Seminars in Arthritis and Rheumatism|December 6, 2016
2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteriaFrederick Wolfe, Daniel J Clauw, Mary-Ann Fitzcharles, et al.Seminars in Arthritis and Rheumatism|December 25, 2016
Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort studyKalle Aaltonen, Arto Heinonen, Jaana Joensuu, et al.Seminars in Arthritis and Rheumatism|March 13, 2017
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) StudyJeffrey A Sparks, Medha Barbhaiya, Elizabeth W Karlson, et al.Seminars in Arthritis and Rheumatism|March 13, 2017
Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysisJosé Ramón Maneiro, Alejandro Souto, Juan J Gomez-ReinoPageof 328